Objective
After completing this educational activity, you should be able to:
 Improve the detection and diagnosis of depression in your practice and help improve treatment response and prevent relapse and recurrence
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Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc., designates this educational activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release, Review, and Expiration Dates
This Performance Improvement CME activity was published in May 2010 and is eligible for AMA PRA Category 1 Credit through May 31, 2013. The latest review of this material was April 2010.
Statement of Need and Purpose
Depression is one of the leading causes of disability and affects 121 million people worldwide, yet it continues to be undertreated. With so many antidepressants available, clinicians may have difficulty selecting the most appropriate agent for each patient and may resort to a one-size-fits-all treatment approach. Advances in neuroimaging suggest that depression is related to abnormalities in brain structure and functioning, and patients with depression have been shown to have disrupted neurobiological processes, which may affect different symptom domains of mood and behavior.
Additionally, advancements have occurred since the American Psychiatric Association practice guidelines for the treatment of depression were published in 2000, which may improve treatment outcomes for patients with depression. Clinicians need more information on current practices and neurobiological processes to optimize treatments for patients with depression and increase the likelihood of remission.
Depression
This activity was designed to meet the needs of participants in CME activities provided by the CME Institute of Physicians Postgraduate Press, Inc., who have requested information on depression.
Review Process
The entire faculty of the series discussed the content at a peer-reviewed planning session, the Chair reviewed the activity for accuracy and fair balance, and a member of the External Advisory CME Board who is without conflict of interest reviewed the activity to determine whether the material is evidencebased and objective.
Abstract
Web Activity Posting Date: May 2010 Performance Improvement CME: Improving Outcomes in Depression Alan J Gelenberg, MD, and Michael E. Thase, MD Performance Improvement CME (PI CME) is an educational activity in which clinicians retrospectively assess their current clinical practice, choose areas for improvement and implement interventions based on treatment guidelines and health care standards, and then re-evaluate their clinical practice to assess the improvements made. This PI CME focuses on improving the detection and initial treatment of depression, enhancing patients' treatment response, and preventing relapse and recurrence. 
